​

Agios Pharmaceuticals (AGIO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Agios Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$36.50M

Latest Revenue (Q)

$8.96M

Main Segment (Y)

Product

Agios Pharmaceuticals Revenue by Period

Agios Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$36.50M36.07%
2023-12-31$26.82M88.36%
2022-12-31$14.24M100.00%
2021-12-31--100.00%
2020-12-31$203.20M72.33%
2019-12-31$117.91M24.92%
2018-12-31$94.39M119.45%
2017-12-31$43.01M-38.46%
2016-12-31$69.89M18.22%
2015-12-31$59.12M-9.55%
2014-12-31$65.36M155.82%
2013-12-31$25.55M1.76%
2012-12-31$25.11M14.97%
2011-12-31$21.84M-

Agios Pharmaceuticals generated $36.50M in revenue during NA 2024, up 36.07% compared to the previous quarter, and up 30.95% compared to the same period a year ago.

Agios Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$8.96M4.05%
2024-06-30$8.62M5.20%
2024-03-31$8.19M15.29%
2023-12-31$7.10M-4.00%
2023-09-30$7.40M10.24%
2023-06-30$6.71M19.66%
2023-03-31$5.61M30.14%
2022-12-31$4.31M22.58%
2022-09-30$3.52M-37.01%
2022-06-30$5.58M570.91%
2022-03-31$832.00K100.00%
2021-12-31-100.00%
2021-09-30--100.00%
2021-06-30$37.35M-9.81%
2021-03-31$41.41M-5.98%
2020-12-31$44.05M26.91%
2020-09-30$34.71M-7.07%
2020-06-30$37.35M-57.12%
2020-03-31$87.10M145.76%
2019-12-31$35.44M36.18%
2019-09-30$26.02M-0.75%
2019-06-30$26.22M-13.25%
2019-03-31$30.23M0.71%
2018-12-31$30.01M97.48%
2018-09-30$15.20M-62.39%
2018-06-30$40.41M361.24%
2018-03-31$8.76M-10.58%
2017-12-31$9.80M-13.73%
2017-09-30$11.36M0.11%
2017-06-30$11.35M7.97%
2017-03-31$10.51M-53.60%
2016-12-31$22.65M152.06%
2016-09-30$8.98M28.76%
2016-06-30$6.98M-77.69%
2016-03-31$31.28M403.07%
2015-12-31$6.22M13.47%
2015-09-30$5.48M-58.54%
2015-06-30$13.22M-61.35%
2015-03-31$34.20M133.68%
2014-12-31$14.64M-56.83%
2014-09-30$33.90M303.04%
2014-06-30$8.41M-
2014-03-31$8.41M24.72%
2013-12-31$6.74M7.59%
2013-09-30$6.27M-
2013-06-30$6.27M-
2013-03-31$6.27M-0.22%
2012-12-31$6.28M0.22%
2012-09-30$6.27M-0.32%
2012-06-30$6.29M0.32%
2012-03-31$6.27M-

Agios Pharmaceuticals generated $8.96M in revenue during Q3 2024, up 4.05% compared to the previous quarter, and up 133.55% compared to the same period a year ago.

Agios Pharmaceuticals Revenue Breakdown

Agios Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 20Dec 19
Product$36.50M$26.82M$11.74M$121.09M$59.85M
Royalty--$2.50M$10.26M$10.54M
Research Services---$64.35M$35.95M
Collaboration Revenue, Related Party---$68.27M$39.26M
Commercialization Activity---$3.93M$3.30M
Committee Participation-----
Development Activities-----
Collaboration Revenue, Other----$8.26M

Agios Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Product$10.73M$8.96M$8.62M$8.19M$7.10M$7.40M$6.71M$5.61M$4.31M$3.52M$3.08M$832.00K$39.12M$31.72M$27.58M$22.67M$19.56M$9.14M--
Royalty-------$2.91M$683.00K$3.34M$3.33M$2.97M$2.20M-------
Collaboration Revenue, Related Party----------$2.50M$1.24M$1.21M$5.74M$60.10M$6.84M$5.52M$8.98M--
Research Services------------$214.00K$6.04M------
Commercialization Activity------------$1.02M$804.00K$821.00K$824.00K----
Collaboration Revenue, Other----------------$6.06M$970.00K--
DevelopmentActivitiesMember--------------------
ResearchServicesMember-----------------$4.70M$8.15M-

Agios Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Agios Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BMRNBioMarin Pharmaceutical$2.85B$733.87B
BPMCBlueprint Medicines$508.82M$128.18M
ARVNArvinas$263.40M$102.40M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
ANABAnaptysBio$91.28M$30.02M
NRIXNurix Therapeutics$54.55M$18.45M
KYMRKymera Therapeutics$47.07M$3.74M
MRSNMersana Therapeutics$40.50M$12.60M
STOKStoke Therapeutics$36.55M$4.89M
AGIOAgios Pharmaceuticals$36.50M$8.96M
MGTXMeiraGTx$33.28M$10.91M
SNDXSyndax Pharmaceuticals$23.68M$12.50M
CCCCC4 Therapeutics$20.76M-
RLAYRelay Therapeutics$10.01M-
IDYAIDEAYA Biosciences$7.00M-
KROSKeros Therapeutics$3.55M$37.00K
CGEMCullinan Oncology--
BDTXBlack Diamond Therapeutics--
COGTCogent Biosciences--
KALVKalVista Pharmaceuticals--
RVMDRevolution Medicines--
PLRXPliant Therapeutics--
MREOMereo BioPharma Group--

AGIO Revenue FAQ

What is Agios Pharmaceuticals’s yearly revenue?

Agios Pharmaceuticals's yearly revenue for 2024 was $36.5M, representing an increase of 36.07% compared to 2023. The company's yearly revenue for 2023 was $26.82M, representing an increase of 88.36% compared to 2022. AGIO's yearly revenue for 2022 was $14.24M, representing an increase of 100.00% compared to 2021.

What is Agios Pharmaceuticals’s quarterly revenue?

Agios Pharmaceuticals's quarterly revenue for Q3 2024 was $8.96M, a 4.05% increase from the previous quarter (Q2 2024), and a 21.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $8.62M, a 5.20% increase from the previous quarter (Q1 2024), and a 28.35% increase year-over-year (Q2 2023). AGIO's quarterly revenue for Q1 2024 was $8.19M, a 15.29% increase from the previous quarter (Q4 2023), and a 46.00% increase year-over-year (Q1 2023).

What is Agios Pharmaceuticals’s revenue growth rate?

Agios Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 156.31%, and for the last 5 years (2020-2024) was -82.04%.

What are Agios Pharmaceuticals’s revenue streams?

Agios Pharmaceuticals's revenue streams in c 24 are Product

What is Agios Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Agios Pharmaceuticals was Product. This segment made a revenue of $36.5M, representing 100.00% of the company's total revenue.